Standard Life Aberdeen »

Mereo Biopharma Group Plc ads shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 1.6M 2.31

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding Mereo Biopharma Group Plc ads

Soleus Capital Management
683 Capital Management
Tejara Capital
Clearline Capital
Goldman Sachs Group
Standard Life Aberdeen
Millennium Management
DAFNA Capital Management
Monaco Asset Management SAM
Citadel Advisors
Toroso Investments
Two Sigma Investments
Squarepoint Ops
J. Goldman & Co
Knoll Capital Management

View all funds holding Mereo Biopharma Group Plc ads